JPRN-UMIN000028169Recruiting未知
Effects of denosumab for bone resorption in the femur after total hip arthroplasty - Effects of denosumab for bone resorption in the femur after total hip arthroplasty
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Yokohama City University
- Enrollment
- 80
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1) Severe renal failure (CCr:less than 30mL/min) (2) Hypercalcemea or hypocalcemia (3) Past history of femoral osteotomy (4) Systemic bone disease (5) Patients, who are considered to be inappropriate for this study by doctors.
Investigators
Similar Trials
Completed
Not Applicable
Effects of denosumab on the treatment of osteoporosis and inhibition of bone erosion in rheumatoid arthritisRheumatoid ArthritisJPRN-UMIN000042107Department of Orthopedic Surgery, Tohoku University Graduate School of Medicine200
Recruiting
Not Applicable
Effects of denosumab on bones in patients with cementless total hip arthroplastyJPRN-UMIN000018260Saitama Medical University100
Active, not recruiting
Not Applicable
A clinical trial to find out whether a medication, called denosumab, has an effect on the bone surrounding a hip joint replacementEUCTR2011-000541-20-GBSheffield Teaching Hospitals NHS Foundation Trust30
Completed
Phase 2
Denosumab and Osteoporotic Vertebral Compression FractureOsteoporotic Vertebral Compression FractureNCT05058443Shenzhen People's Hospital90
Completed
Not Applicable
The effect of denosumab for the treatment of osteoporosis in hemodialysis patientsOsteoporosisJPRN-UMIN000014458Saiseikai Kumamoto Hospital40